DNPs of Color Discuss Systemic Racism and Overcoming Imposter Syndrome
Implicit bias and systemic racism continues to challenge nurse practitioners of color. Breaking the glass ceiling of color will be one way to gain a seat at the table.
Policy
Update on Medications for Opioid Use Disorder: Clinician Perspectives
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
Special ACA Enrollment Window Brings Insurance to 500,000 Americans
Patients who were already enrolled in the ACA at the beginning of this year are also entitled to the increased financial aid.
Presenteeism: How Flawed Medical Systems Incentivize Risk to Patients
During the COVID-19 pandemic, clinicians should be extremely mindful of assessing their own symptoms before making the decision about whether to treat patients or stay home.
Lifting COVID-19 “Lockdown” Restrictions May Cause Infection Resurgence
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
ACP: US Response to COVID-19 Identifies Inequalities in Health Care System
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
FDA: Guidance on Digital Therapeutics for Psychiatric Disorders During COVID-19
The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.
Drug Shortages Reported as New Program Created to Expedite Treatments for COVID-19
To expedite development, the FDA has created a special emergency program called the Coronavirus Treatment Acceleration Program.
Compliance With FDA Reporting Guidelines for Clinical Trials Is Low, Not Improving
Cohort study data from 2018 to 2019 suggest poor compliance with the US Food and Drug Administration reporting requirements for clinical trial sponsors.
Say Goodbye to High-Stakes Recertification? NCCPA Pilots Alternative Recertification Testing
Many providers who are required to take recertification examinations feel as though standard CMS is just as effective in skill maintenance as studying and sitting for a 200-question examination.
- Loading...
Loading...
Next post in The Waiting Room
Loading... 
Loading...